@Purdue_RCHE 1 year ago
Petros Drineas: Prof./Assoc. Head of @PurdueCS and the #RCHE Assoc. Dir of Health #DataScience. His focus is on genetic variation to inform the risk of disease & characterize #healthconditions and improve medical interventions and therapeutics. #Purdue #Healthcare #Research https://t.co/uFQuFq57JB
@tech.eu 1 year ago
More than a Sidekick! Iceland’s digital therapeutics player kicks in $55 million to boost chronic disease treatments
@xconomy.com 3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed